Assessing the oncogenic risk: the long-term safety of autologous chimeric antigen receptor T cells.

Baker DJ, Levine BL, June CH. Lancet. 2025 Mar 1;405(10480):751-754. doi: 10.1016/S0140-6736(25)00039-X. PMID: 40023653